During the Q3 CC, the management talked in length about “important pilot programs with several national distribution companies who see the clinical and market potential for SENSUS.” Those pilot programs started in Q3.
The first major commitment from one of those pilot programs came on Oct. 15, 2013, when the company entered into an agreement with OsteoArthritis Centers of America, a national physician consulting company, to incorporate the SENSUS™ into its 100+ affiliated medical clinics nationwide.
That basically was the first concrete indication that the pilot programs are starting to bear fruits already. There’re 19 major national distribution channels in the US. I think we’ll will see some more of those big distributors to come on board in the coming days/weeks and months.
That’s exciting, isn’t it? At the start of a new business platform for such an unique and revolutionary product for diabetics, good news will keep coming our way steadily.
Those are reasons why the investors will be big winners going forward. You never know when the next big news will be released. And this trading game will see endless short squeezes throughout 2014.
Don't know who grant is but he sure has an interesting stock blog with a twist on how the shorts influence pps. Some impressive analytical research on Nuro too. Going back thru the archives his Nuro calls have been good.